These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
649 related articles for article (PubMed ID: 29886090)
1. The Institutional Learning Curve of Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy: Temporal Improvements in Cancer Detection in 4 Years. Meng X; Rosenkrantz AB; Huang R; Deng FM; Wysock JS; Bjurlin MA; Huang WC; Lepor H; Taneja SS J Urol; 2018 Nov; 200(5):1022-1029. PubMed ID: 29886090 [TBL] [Abstract][Full Text] [Related]
2. Optimizing the Number of Cores Targeted During Prostate Magnetic Resonance Imaging Fusion Target Biopsy. Kenigsberg AP; Renson A; Rosenkrantz AB; Huang R; Wysock JS; Taneja SS; Bjurlin MA Eur Urol Oncol; 2018 Oct; 1(5):418-425. PubMed ID: 31158081 [TBL] [Abstract][Full Text] [Related]
3. Anterior Localization of Prostate Cancer Suspicious Lesions in 1,161 Patients Undergoing Magnetic Resonance Imaging/Ultrasound Fusion Guided Targeted Biopsies. Leyh-Bannurah SR; Kachanov M; Beyersdorff D; Preisser F; Tilki D; Fisch M; Graefen M; Budäus L J Urol; 2018 Nov; 200(5):1035-1040. PubMed ID: 29935274 [TBL] [Abstract][Full Text] [Related]
4. Accuracy of Transperineal Targeted Prostate Biopsies, Visual Estimation and Image Fusion in Men Needing Repeat Biopsy in the PICTURE Trial. Simmons LAM; Kanthabalan A; Arya M; Briggs T; Barratt D; Charman SC; Freeman A; Hawkes D; Hu Y; Jameson C; McCartan N; Moore CM; Punwani S; van der Muelen J; Emberton M; Ahmed HU J Urol; 2018 Dec; 200(6):1227-1234. PubMed ID: 30017964 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Initial Experience with Transrectal Magnetic Resonance Imaging Cognitive Guided Micro-Ultrasound Biopsies versus Established Transperineal Robotic Ultrasound Magnetic Resonance Imaging Fusion Biopsies for Prostate Cancer. Claros OR; Tourinho-Barbosa RR; Fregeville A; Gallardo AC; Muttin F; Carneiro A; Stabile A; Moschini M; Macek P; Cathala N; Mombet A; Sanchez-Salas R; Cathelineau X J Urol; 2020 May; 203(5):918-925. PubMed ID: 31821099 [TBL] [Abstract][Full Text] [Related]
6. Is it Time to Perform Only Magnetic Resonance Imaging Targeted Cores? Our Experience with 1,032 Men Who Underwent Prostate Biopsy. Pepe P; Garufi A; Priolo GD; Galia A; Fraggetta F; Pennisi M J Urol; 2018 Oct; 200(4):774-778. PubMed ID: 29679618 [TBL] [Abstract][Full Text] [Related]
7. The detection of significant prostate cancer is correlated with the Prostate Imaging Reporting and Data System (PI-RADS) in MRI/transrectal ultrasound fusion biopsy. Cash H; Maxeiner A; Stephan C; Fischer T; Durmus T; Holzmann J; Asbach P; Haas M; Hinz S; Neymeyer J; Miller K; Günzel K; Kempkensteffen C World J Urol; 2016 Apr; 34(4):525-32. PubMed ID: 26293117 [TBL] [Abstract][Full Text] [Related]
8. Impact of real-time elastography on magnetic resonance imaging/ultrasound fusion guided biopsy in patients with prior negative prostate biopsies. Brock M; Löppenberg B; Roghmann F; Pelzer A; Dickmann M; Becker W; Martin-Seidel P; Sommerer F; Schenk L; Palisaar RJ; Noldus J; von Bodman C J Urol; 2015 Apr; 193(4):1191-7. PubMed ID: 25451832 [TBL] [Abstract][Full Text] [Related]
9. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care? Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824 [TBL] [Abstract][Full Text] [Related]
10. Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR. Rosenkrantz AB; Verma S; Choyke P; Eberhardt SC; Eggener SE; Gaitonde K; Haider MA; Margolis DJ; Marks LS; Pinto P; Sonn GA; Taneja SS J Urol; 2016 Dec; 196(6):1613-1618. PubMed ID: 27320841 [TBL] [Abstract][Full Text] [Related]
11. Detection rate of clinically significant prostate cancer in magnetic resonance imaging and ultrasonography-fusion transperineal targeted biopsy for lesions with a prostate imaging reporting and data system version 2 score of 3-5. Hakozaki Y; Matsushima H; Murata T; Masuda T; Hirai Y; Oda M; Kawauchi N; Yokoyama M; Kume H Int J Urol; 2019 Feb; 26(2):217-222. PubMed ID: 30461076 [TBL] [Abstract][Full Text] [Related]
12. Validation of Prostate Imaging Reporting and Data System Version 2 for the Detection of Prostate Cancer. Hofbauer SL; Maxeiner A; Kittner B; Heckmann R; Reimann M; Wiemer L; Asbach P; Haas M; Penzkofer T; Stephan C; Friedersdorff F; Fuller F; Miller K; Cash H J Urol; 2018 Oct; 200(4):767-773. PubMed ID: 29733838 [TBL] [Abstract][Full Text] [Related]
13. Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results. Tewes S; Hueper K; Hartung D; Imkamp F; Herrmann TR; Weidemann J; Renckly S; Kuczyk MA; Wacker F; Peters I World J Urol; 2015 Nov; 33(11):1707-14. PubMed ID: 25774003 [TBL] [Abstract][Full Text] [Related]
14. Accuracy of real-time magnetic resonance imaging-transrectal ultrasound fusion image-guided transperineal target biopsy with needle tracking with a mechanical position-encoded stepper in detecting significant prostate cancer in biopsy-naïve men. Shoji S; Hiraiwa S; Ogawa T; Kawakami M; Nakano M; Hashida K; Sato Y; Hasebe T; Uchida T; Tajiri T Int J Urol; 2017 Apr; 24(4):288-294. PubMed ID: 28222486 [TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance. Radtke JP; Kuru TH; Boxler S; Alt CD; Popeneciu IV; Huettenbrink C; Klein T; Steinemann S; Bergstraesser C; Roethke M; Roth W; Schlemmer HP; Hohenfellner M; Hadaschik BA J Urol; 2015 Jan; 193(1):87-94. PubMed ID: 25079939 [TBL] [Abstract][Full Text] [Related]
16. Defining Novel and Practical Metrics to Assess the Deliverables of Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy. Ristau BT; Chen DYT; Ellis J; Malhotra A; DeMora L; Parsons RB; Milestone B; Brody M; Viterbo R; Greenberg R; Smaldone M; Uzzo R; Anaokar J; Kutikov A J Urol; 2018 Apr; 199(4):969-975. PubMed ID: 28988963 [TBL] [Abstract][Full Text] [Related]
17. Risk of Prostate Cancer after a Negative Magnetic Resonance Imaging Guided Biopsy. Kinnaird A; Sharma V; Chuang R; Priester A; Tran E; Barsa DE; Delfin M; Kwan L; Sisk A; Felker E; Marks LS J Urol; 2020 Dec; 204(6):1180-1186. PubMed ID: 32614257 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging and Fusion Guided Targeted Biopsy Evaluated by Transperineal Template Saturation Prostate Biopsy for the Detection and Characterization of Prostate Cancer. Mortezavi A; Märzendorfer O; Donati OF; Rizzi G; Rupp NJ; Wettstein MS; Gross O; Sulser T; Hermanns T; Eberli D J Urol; 2018 Aug; 200(2):309-318. PubMed ID: 29474846 [TBL] [Abstract][Full Text] [Related]
19. A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial. Wysock JS; Rosenkrantz AB; Huang WC; Stifelman MD; Lepor H; Deng FM; Melamed J; Taneja SS Eur Urol; 2014 Aug; 66(2):343-51. PubMed ID: 24262102 [TBL] [Abstract][Full Text] [Related]
20. Comparative Effectiveness of Targeted Prostate Biopsy Using Magnetic Resonance Imaging Ultrasound Fusion Software and Visual Targeting: a Prospective Study. Lee DJ; Recabal P; Sjoberg DD; Thong A; Lee JK; Eastham JA; Scardino PT; Vargas HA; Coleman J; Ehdaie B J Urol; 2016 Sep; 196(3):697-702. PubMed ID: 27038768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]